Qibing Leng

10PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyAutoimmunityTumour immunologyChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 12, 2025
In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8<sup>+</sup> T cell responses.

Mengjiao Wang, Li Qiu, Cheng Tang

|Jul 17, 2023
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Yan Mei, Xiumei Wang, Ji Zhang

|Sep 16, 2021
Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer.

Huanjun Wang, Yan Mei, Cheng Luo

|Sep 28, 2020
Interleukin-8 as a candidate for thymoma identification and recurrence surveillance.

Shilin Gao, Jiahao Jiang, Chun Jin

|Mar 27, 2020
Pre-existing heterologous T-cell immunity and neoantigen immunogenicity.

Qibin Leng, Marion Tarbe, Qi Long

|Aug 22, 2019
TSC1/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis.

Lei Shi, Xia Chen, Aiping Zang

Pageof 2

Frequent Collaborators

2 joint publications

Guangshuai Jia

1 joint publications

Ruth T Yu

1 joint publications

Christopher Liddle

1 joint publications

Ye Zheng